159 related articles for article (PubMed ID: 22100756)
1. Self-assembly and liver targeting of sulfated chitosan nanoparticles functionalized with glycyrrhetinic acid.
Tian Q; Wang XH; Wang W; Zhang CN; Wang P; Yuan Z
Nanomedicine; 2012 Aug; 8(6):870-9. PubMed ID: 22100756
[TBL] [Abstract][Full Text] [Related]
2. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
Tian Q; Zhang CN; Wang XH; Wang W; Huang W; Cha RT; Wang CH; Yuan Z; Liu M; Wan HY; Tang H
Biomaterials; 2010 Jun; 31(17):4748-56. PubMed ID: 20303163
[TBL] [Abstract][Full Text] [Related]
3. Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.
Qi WW; Yu HY; Guo H; Lou J; Wang ZM; Liu P; Sapin-Minet A; Maincent P; Hong XC; Hu XM; Xiao YL
Mol Pharm; 2015 Mar; 12(3):675-83. PubMed ID: 25584860
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of polymeric micelles based on hydrophobically-modified sulfated chitosan as a carrier of doxorubicin.
Wang XH; Tian Q; Wang W; Zhang CN; Wang P; Yuan Z
J Mater Sci Mater Med; 2012 Jul; 23(7):1663-74. PubMed ID: 22538726
[TBL] [Abstract][Full Text] [Related]
5. Glycyrrhetinic acid-modified poly(ethylene glycol)-b-poly(gamma-benzyl l-glutamate) micelles for liver targeting therapy.
Huang W; Wang W; Wang P; Tian Q; Zhang C; Wang C; Yuan Z; Liu M; Wan H; Tang H
Acta Biomater; 2010 Oct; 6(10):3927-35. PubMed ID: 20438873
[TBL] [Abstract][Full Text] [Related]
6. Enhanced delivery of doxorubicin to the liver through self-assembled nanoparticles formed via conjugation of glycyrrhetinic acid to the hydroxyl group of hyaluronic acid.
Wang X; Gu X; Wang H; Yang J; Mao S
Carbohydr Polym; 2018 Sep; 195():170-179. PubMed ID: 29804965
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapy.
Zhang C; Wang W; Liu T; Wu Y; Guo H; Wang P; Tian Q; Wang Y; Yuan Z
Biomaterials; 2012 Mar; 33(7):2187-96. PubMed ID: 22169820
[TBL] [Abstract][Full Text] [Related]
8. Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer.
Yang T; Lan Y; Cao M; Ma X; Cao A; Sun Y; Yang J; Li L; Liu Y
Colloids Surf B Biointerfaces; 2019 Mar; 175():106-115. PubMed ID: 30529816
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of glycyrrhetinic acid-modified stearic acid-grafted chitosan micelles.
Chen Q; Sun Y; Wang J; Yan G; Cui Z; Yin H; Wei H
Artif Cells Nanomed Biotechnol; 2015; 43(4):217-23. PubMed ID: 24093764
[TBL] [Abstract][Full Text] [Related]
10. Insight into glycyrrhetinic acid: the role of the hydroxyl group on liver targeting.
Tian Q; Wang X; Wang W; Zhang C; Liu Y; Yuan Z
Int J Pharm; 2010 Nov; 400(1-2):153-7. PubMed ID: 20813176
[TBL] [Abstract][Full Text] [Related]
11. Effective co-delivery of doxorubicin and curcumin using a glycyrrhetinic acid-modified chitosan-cystamine-poly(ε-caprolactone) copolymer micelle for combination cancer chemotherapy.
Yan T; Li D; Li J; Cheng F; Cheng J; Huang Y; He J
Colloids Surf B Biointerfaces; 2016 Sep; 145():526-538. PubMed ID: 27281238
[TBL] [Abstract][Full Text] [Related]
12. Codelivery of Doxorubicin and shAkt1 by Poly(ethylenimine)-Glycyrrhetinic Acid Nanoparticles To Induce Autophagy-Mediated Liver Cancer Combination Therapy.
Wang FZ; Xing L; Tang ZH; Lu JJ; Cui PF; Qiao JB; Jiang L; Jiang HL; Zong L
Mol Pharm; 2016 Apr; 13(4):1298-307. PubMed ID: 26894988
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of galactosylated glycol chitosan micelles and its potential use for hepatoma-targeting delivery of doxorubicin.
Yu JM; Li WD; Lu L; Zhou XY; Wang DY; Li HM; Xu XY; Chen J
J Mater Sci Mater Med; 2014 Mar; 25(3):691-701. PubMed ID: 24338380
[TBL] [Abstract][Full Text] [Related]
14. Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin.
Du H; Liu M; Yu A; Ji J; Zhai G
Int J Pharm; 2017 May; 523(1):427-438. PubMed ID: 28359815
[TBL] [Abstract][Full Text] [Related]
15. Fabrication and characterization of nuclear localization signal-conjugated glycol chitosan micelles for improving the nuclear delivery of doxorubicin.
Yu J; Xie X; Zheng M; Yu L; Zhang L; Zhao J; Jiang D; Che X
Int J Nanomedicine; 2012; 7():5079-90. PubMed ID: 23049255
[TBL] [Abstract][Full Text] [Related]
16. Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer.
Yang Y; Yuan SX; Zhao LH; Wang C; Ni JS; Wang ZG; Lin C; Wu MC; Zhou WP
Mol Pharm; 2015 Feb; 12(2):644-52. PubMed ID: 25495890
[TBL] [Abstract][Full Text] [Related]
17. Cellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicin.
Hu FQ; Wu XL; Du YZ; You J; Yuan H
Eur J Pharm Biopharm; 2008 May; 69(1):117-25. PubMed ID: 17997293
[TBL] [Abstract][Full Text] [Related]
18. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
Zhang L; Yao J; Zhou J; Wang T; Zhang Q
Int J Pharm; 2013 Jan; 441(1-2):654-64. PubMed ID: 23117024
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles.
Hu FQ; Liu LN; Du YZ; Yuan H
Biomaterials; 2009 Dec; 30(36):6955-63. PubMed ID: 19782395
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of SiO2-deposited stearic acid-g-chitosan nanoparticles for doxorubicin delivery.
Yuan H; Bao X; Du YZ; You J; Hu FQ
Int J Nanomedicine; 2012; 7():5119-28. PubMed ID: 23055724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
